DiaSorin
Employees
View Company Info for Free
Overview
Website
diasoringroup.comRevenue
-
ZI Rank: 11
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
10
2
1
8
10
11
DiaSorin Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DiaSorin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at DiaSorin
Website visits: Recent activity has been detected on your website
Check if DiaSorin has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when DiaSorin launches new products
Funding: Get notified immidiatlly once DiaSorin has new funding data
Earning: See what the market has to say on DiaSorin recently announced quarterly report
Check out if DiaSorin is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
DiaSorin, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if DiaSorin had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
DiaSorin financials insights
Gather financial insights about DiaSorin, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$31M
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
DiaSorin News & Media
DiaSorin S.p.A. (DSRLF) Q2 2024 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...DiaSorin S.p.A. (DSRLF) Q4 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2023 Earnings Conference Call March 15, 2024 10:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...DiaSorin S.p.A. (DSRLF) Q3 2023 Earnings Call Transcript
DiaSorin S.p.A. (OTCPK:DSRLF) Q3 2023 Earnings Conference Call November 3, 2023 11:30 AM ETCompany ParticipantsCarlo Rosa - Chief Executive...Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million.
Read more news
Frequently Asked Questions Regarding DiaSorin
Sign Up For FreeTo access detailed company insights
